Whole‐exome sequencing of secondary tumors arising from nevus sebaceous revealed additional genomic alterations besides RAS mutations
- 20 March 2023
- journal article
- research article
- Published by Wiley in The Journal of Dermatology
- Vol. 50 (8) , 1072-1075
Abstract
Nevus sebaceous (NS) is a congenital hamartoma associated with an increased risk of secondary neoplasms in approximately 10%-20% of patients. However, additional genomic alterations underlying tumorigenesis in NS lesions have not been clarified. We performed whole-exome sequencing of archived tumor tissues (n = 8; six basal cell carcinomas and two trichoepitheliomas) and matched germline tissues (n = 7) with from seven patients with secondary tumors arising from NS. We also analyzed NS lesions without secondary tumors (n = 8). Somatic mutations and copy number alterations (CNAs) were analyzed. We identified a median of 129 somatic mutations (corresponding to 2.6/Mb in target regions, range 26-336) for eight tumors, while a median of 118 somatic mutations (2.3/Mb, range 1-196) for eight NS lesions. Known RAS hotspot mutations were found in seven of the eight tumors (six for HRAS p.G13R and one for HRAS p.Q61R) and in six of the eight NS lesions (four for HRAS p.G13R, one for KRAS p.G12C, and one KRAS p.G12D). Except RAS mutations, several putative driver mutations were detected in tumors: TP53 p.F134L/p.R213*, MYCN p.P59L, OR2Z1 p.P167S, PTPN14 p.Q768*, and SMO p.W535L. As for CNAs, two tumors harbored copy-loss in regions encompassing PTCH1 gene. However, eight NS lesions did not harbor both putative driver mutations and CNAs. In conclusion, our study revealed that secondary tumors arising from NS harbor known RAS hotspot mutations and additional genomic alterations, including putative driver mutations and PTCH1 copy-loss. These results could help to define the high-risk group for tumor development in patients with NS and provide evidence for prophylactic resection.Keywords
Funding Information
- Korea Health Industry Development Institute
- National Research Foundation of Korea
This publication has 13 references indexed in Scilit:
- FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencingNucleic Acids Research, 2016
- Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinomaNature Genetics, 2016
- Secondary neoplasms associated with nevus sebaceus of Jadassohn: A study of 707 casesJournal of the American Academy of Dermatology, 2014
- Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemiaHuman Molecular Genetics, 2013
- Whole-Exome Sequencing Reveals Somatic Mutations in HRAS and KRAS, which Cause Nevus SebaceusJournal of Investigative Dermatology, 2013
- Mosaic Activating RAS Mutations in Nevus Sebaceus and Nevus Sebaceus SyndromeJournal of Investigative Dermatology, 2013
- Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndromeNature Genetics, 2012
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingGenome Research, 2012
- HRASMutation Mosaicism Causing Urothelial Cancer and Epidermal NevusNew England Journal of Medicine, 2011
- Sebaceus naevi: a clinicopathologic studyJournal of the European Academy of Dermatology and Venereology, 2002